Abstract
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that must be diagnosed early to increase drug therapy efficacy. No early definitive diagnostic tool, however, is currently available, thus prompting for the identification of biomarkers of the disease. Isoprostanes (iPs) are prostaglandin-related free radical oxidation products of polyunsaturated fatty acids (PUFA) that are produced under oxidative stress conditions that occur, for instance, in the brain of AD sufferers. iPs are stable lipids known to partition in bodily fluids and are thus interesting potential biomarkers of AD. However, resolution of iPs by reverse phase HPLC is complicated by the existence of multiple regioisomers and enantiomers. Consequently, we have developed two normal phase chiral approaches for the detailed analysis of the F2-iP class of isoprostanes. First, normal phase chiral LC-MS/MS permitted the identification and quantification of four types of F2- iPs in urine samples from control, mild cognitive impairment (MCI) patients and severe AD sufferers. Second, given its suitability for non-polar compounds analysis and chiral separations, supercritical fluid chromatography (SFC) was investigated as an alternative approach. SFC-MS/MS enabled the identification of regioisomers and enantiomers of F2-iPs. Identification of analytes was undertaken by MRM monitoring of diagnostic transitions while the chiral chromatography allowed for the resolution of enantiomers within types. F-iPs could be reproducibly identified and quantified.
Keywords: Supercritical fluid chromatography, SFC, mass spectrometry, chiral separation, isoprostanes, Alzheimer’s disease.
Current Analytical Chemistry
Title:Investigation of Isoprostanes as Potential Biomarkers for Alzheimer's Disease Using Chiral LC-MS/MS and SFC-MS/MS
Volume: 10 Issue: 1
Author(s): Victoria Goss, Amaury Cazenave-Gassiot, Ashley Pringle and Anthony Postle
Affiliation:
Keywords: Supercritical fluid chromatography, SFC, mass spectrometry, chiral separation, isoprostanes, Alzheimer’s disease.
Abstract: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that must be diagnosed early to increase drug therapy efficacy. No early definitive diagnostic tool, however, is currently available, thus prompting for the identification of biomarkers of the disease. Isoprostanes (iPs) are prostaglandin-related free radical oxidation products of polyunsaturated fatty acids (PUFA) that are produced under oxidative stress conditions that occur, for instance, in the brain of AD sufferers. iPs are stable lipids known to partition in bodily fluids and are thus interesting potential biomarkers of AD. However, resolution of iPs by reverse phase HPLC is complicated by the existence of multiple regioisomers and enantiomers. Consequently, we have developed two normal phase chiral approaches for the detailed analysis of the F2-iP class of isoprostanes. First, normal phase chiral LC-MS/MS permitted the identification and quantification of four types of F2- iPs in urine samples from control, mild cognitive impairment (MCI) patients and severe AD sufferers. Second, given its suitability for non-polar compounds analysis and chiral separations, supercritical fluid chromatography (SFC) was investigated as an alternative approach. SFC-MS/MS enabled the identification of regioisomers and enantiomers of F2-iPs. Identification of analytes was undertaken by MRM monitoring of diagnostic transitions while the chiral chromatography allowed for the resolution of enantiomers within types. F-iPs could be reproducibly identified and quantified.
Export Options
About this article
Cite this article as:
Goss Victoria, Cazenave-Gassiot Amaury, Pringle Ashley and Postle Anthony, Investigation of Isoprostanes as Potential Biomarkers for Alzheimer's Disease Using Chiral LC-MS/MS and SFC-MS/MS, Current Analytical Chemistry 2014; 10 (1) . https://dx.doi.org/10.2174/1573411011410010010
DOI https://dx.doi.org/10.2174/1573411011410010010 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
Call for Papers in Thematic Issues
Advancements in biomedicine, corrosion inhibition/monitoring, and lubrication of carbon dots
Carbon dots, a class of carbon-based nanomaterials, have garnered substantial interest in various scientific and engineering fields due to their unique properties, including excellent optical properties, outstanding biocompatibility, easy preparation, good dispersity, ultrasmall size, low toxicity and environmental friendliness. This special issue of Current Analytical Chemistry aims to showcase cutting-edge ...read more
Advances in Microfluidic and Sensing Technologies of Biofluids.
Detection of biological fluids is an important means to assess human health and diagnose diseases. Currently, research on blood is relatively mature and widely applied in the medical field. With the development and advancement of microfluidic technology and novel detection methods, attention has turned to human physiological fluids such as ...read more
Analytical methods for environmental and food analysis
In recent years, the study of the chemical composition of food and the environment depends on analytical methods in order to acquire information about the chemical composition, processing, quality control and contamination of soil, water, air, plants and foods, aspects very important for food safety and environmental quality control. There ...read more
Applications of artificial intelligence in chemical analysis
Artificial intelligence (AI) has demonstrated its versatility in almost all scientific fields, especially analytical chemistry, which is leading the way in the integration of AI. According to Chemical Abstract Services, one of the major disciplines contributing to AI-related publications and patents is analytical chemistry. That?s because techniques such as deep ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Relationship Between the Japanese Version of the Montreal Cognitive Assessment and PET Imaging in Subjects with Mild Cognitive Impairment
Current Alzheimer Research Molecular Biology of Nucleoside Transporters and their Distributions and Functions in the Brain
Current Topics in Medicinal Chemistry Role of Metals in Neuronal Apoptosis: Challenges Associated with Neurodegeneration
Current Alzheimer Research Current Advances on Different Kinases Involved in Tau Phosphorylation, and Implications in Alzheimers Disease and Tauopathies
Current Alzheimer Research Ectonucleotidases and Nucleotide/Nucleoside Transporters as Pharmacological Targets for Neurological Disorders
CNS & Neurological Disorders - Drug Targets Glaucoma: Validated and Facile In Vivo Experimental Models of a Chronic Neurodegenerative Disease for Drug Development
Current Medicinal Chemistry - Central Nervous System Agents Current Update on Synopsis of miRNA Dysregulation in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Occupational Complexity and Leisure Activities in Cognitive Aging
Current Psychopharmacology The Multifactorial Nature of Alzheimer's Disease for Developing Potential Therapeutics
Current Topics in Medicinal Chemistry Stem Cells: In Sickness and in Health
Current Stem Cell Research & Therapy Brain Innate Immunity in the Regulation of Neuroinflammation: Therapeutic Strategies by Modulating CD200-CD200R Interaction Involve the Cannabinoid System
Current Pharmaceutical Design Ketamine: New Indications for an Old Drug
Current Drug Targets Neuronal Response of Peroxisomal and Peroxisome-Related Proteins to Chronic and Acute Aβ Injury
Current Alzheimer Research Epigenetic Drugs in Cognitive Disorders
Current Pharmaceutical Design Parkinson’s Disease and Alpha-Synucleinopathies: from Arising Pathways to Therapeutic Challenge
Central Nervous System Agents in Medicinal Chemistry Getting to Know the Cast - Cellular Interactions and Signaling at the Neurovascular Unit
Current Pharmaceutical Design Macrophage Colony-Stimulating Factor (M-CSF) in Plasma and CSF of Patients with Mild Cognitive Impairment and Alzheimers Disease
Current Alzheimer Research The Role of Oxidative Stress in Depressive Disorders
Current Pharmaceutical Design Obesity Pharmacotherapy: Current Perspectives and Future Directions
Current Cardiology Reviews Understanding the Potential Role and Delivery Approaches of Nitric Oxide in Chronic Wound Healing Management
Current Pharmaceutical Design